巨噬细胞在脓毒症心肌病发病机制中的作用
脓毒症心肌病是脓毒症导致的可逆性心肌功能障碍,其发病机制涉及全身神经免疫机制和心肌细胞局部改变两方面。免疫功能障碍是导致脓毒症心肌病患者预后不良的关键因素之一。心脏巨噬细胞是心脏中异质性最强的免疫细胞之一,按来源和分化分为骨髓来源的组织浸润巨噬细胞和心脏驻留巨噬细胞。在脓毒症心肌病中,血源性募集的心脏巨噬细胞通过促炎与抗炎表型转换参与心肌组织炎症与修复的平衡,心脏驻留巨噬细胞介导免疫吞噬维持心肌细胞局部稳态,巨噬细胞的糖代谢重编程调控炎症因子释放。深入理解巨噬细胞生物学行为并调控其极化、代谢和吞噬功能,可能成为脓毒症心肌病防治的新靶点。
要点
- 脓毒症心肌病是脓毒症所致可逆性心肌功能障碍,早期干预需理解其发病机制。
- 免疫功能障碍是脓毒症心肌病患者预后不良的关键因素之一。
- 心脏巨噬细胞按来源和分化分为骨髓来源组织浸润巨噬细胞和心脏驻留巨噬细胞。
- 血源性募集的心脏巨噬细胞通过促炎与抗炎表型转换参与心肌炎症与修复平衡。
- 调控心脏巨噬细胞的极化、代谢和吞噬可能成为脓毒症心肌病防治新靶点。
研究设计与关键结果
- 综述总结脓毒症心肌病发病机制主要集中于全身神经免疫机制和心肌细胞局部改变两方面。
- 全身神经免疫机制主要包括交感神经过度激活所致的自主神经功能障碍和免疫应答紊乱所致的炎症风暴。
- 心肌细胞局部改变涵盖钙稳态失调、线粒体功能障碍和能量代谢紊乱。
- 心脏巨噬细胞具有极化、吞噬、调控炎症反应及参与先天性和适应性免疫的作用。
- 血源性募集的心脏巨噬细胞通过促炎表型与抗炎表型转换参与平衡心肌组织炎症与修复。
- 心脏驻留巨噬细胞介导免疫吞噬以维持心肌细胞局部稳态。
- 巨噬细胞的糖代谢重编程调控炎症因子释放。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,深入理解巨噬细胞生物学行为并调控心脏巨噬细胞的极化、代谢和吞噬,可能成为脓毒症心肌病防治的新靶点。
- 作者认为,本综述揭示了开发脓毒症心肌病防治新策略的可能性。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「适用人群与场景」「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis is a life-threatening organ dysfunction caused by the body's dysregulated response to infection. Reversible myocardial dysfunction caused by sepsis is known as septic cardiomyopathy. A thorough understanding of the pathogenesis of septic cardiomyopathy is crucial for early intervention to prevent its progression and improve the success rate of sepsis treatment. At present, the research on the pathogenesis of septic cardiomyopathy mainly focuses on two aspects: the systemic neuroimmune mechanism and the local changes of cardiomyocytes. The former mainly includes the autonomic nervous dysfunction mainly caused by sympathetic overactivation and the inflammatory storm induced by immune response disorder. The latter covers the dysregulation of calcium homeostasis, mitochondrial dysfunction and energy metabolism disorder of cardiomyocytes. Immune dysfunction is one of the key factors that cause the poor prognosis of patients with septic cardiomyopathy. Macrophages are sentinel cells of the body's innate immunity. Cardiac macrophages have been confirmed to be one of the most heterogeneous immune cells in the heart. According to their origin and differentiation, they can be divided into bone marrow-derived tissue infiltrating macrophages and cardiac resident macrophages, which have roles of polarization, phagocytosis, regulation of inflammatory response, and participate in innate and adaptive immunity. In the occurrence and development of septic cardiomyopathy, cardiac macrophages recruited from the blood participate in balancing the inflammation and repair of myocardial tissue through the conversion of pro-inflammatory phenotype and anti-inflammatory phenotype. Cardiac resident macrophages mediate immune phagocytosis to maintain the local homeostasis of cardiomyocytes, and the glycometabolic reprogramming of macrophages regulates the release of inflammatory factors, while macrophage metabolic reprogramming regulates the release of inflammatory factors. A deeper understanding of the biological behavior of macrophages, and regulating the polarization, metabolism and phagocytosis of cardiac macrophages, could serve as new target for the prevention and treatment of septic cardiomyopathy. Therefore, this article reviews the key pathogenesis of septic cardiomyopathy and the role of macrophages of different origins and differentiation, revealing the possibility of developing new strategies for the prevention and treatment of septic cardiomyopathy.
参考来源
- Zhang L, Zhao Z, Li T, et al. [Role of macrophages in the pathogenesis of septic cardiomyopathy]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2025. PMID: 40202005. doi:10.3760/cma.j.cn121430-20240925-00797
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。